Angiotensin II Type 1 Receptor Antagonist Suppress Angiogenesis and Growth of Gastric Cancer Xenografts
Wei Huang(South China University of Technology), Li-Fen Yu(Ruijin Hospital), Feng-Xiang Jiang(Tongji University), Xianglong Tian(Shanghai Eighth People Hospital), Jie Zhong(Shanghai Jiao Tong University), Yunlin Wu(University Gastroenterology)
Cited by 52
Related Papers
Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy
|Journal of the American Chemical Society|2014|716
m6A-dependent glycolysis enhances colorectal cancer progression
|Molecular Cancer|2020|465
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434
Identification of a cellularly active SIRT6 allosteric activator
|Nature Chemical Biology|2018|272
A long non-coding RNA signature to improve prognosis prediction of gastric cancer
|Molecular Cancer|2016|217